Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing lansoprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole poisoning |
Causative agent (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental lansoprazole poisoning |
Causative agent (attribute) |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional lansoprazole poisoning |
Causative agent (attribute) |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par le lansoprazole d'intention indéterminée |
Causative agent (attribute) |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole adverse reaction |
Causative agent (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to lansoprazole |
Causative agent (attribute) |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole overdose |
Causative agent (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental lansoprazole overdose |
Causative agent (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional lansoprazole overdose |
Causative agent (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de lansoprazole d'intention indéterminée |
Causative agent (attribute) |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 30mg oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 15mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 15mg (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 30mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 15mg gastro-resistant tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 30mg gastro-resistant tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole- and naproxen-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lansoprazole 15mg m/r capsule/naproxen 375mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 15mg m/r capsule/naproxen 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 30mg m/r orally disintegrating capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 15mg m/r orally disintegrating capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 15mg gastro-resistant tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 30mg gastro-resistant tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental lansoprazole poisoning |
Causative agent (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional lansoprazole poisoning |
Causative agent (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 15mg m/r capsule/naproxen 250mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 30 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lansoprazole in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing lansoprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to lansoprazole |
Causative agent (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30mg capsule (substance) |
Has basis of strength substance (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 15 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lansoprazole 30mg capsule (substance) |
Has precise active ingredient |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 15 mg oral capsule |
Has precise active ingredient |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet |
Has precise active ingredient |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30 mg granules for gastro-resistant oral suspension sachet |
Has basis of strength substance (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lansoprazole and naproxen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lansoprazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lansoprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lansoprazole in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 15 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 15 mg orodispersible tablet |
Has precise active ingredient |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30 mg orodispersible tablet |
Has precise active ingredient |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lansoprazole 30 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lansoprazole in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing lansoprazole in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lansoprazole (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |